EQUITY TRANSACTIONS

9 Months Ended

Jan. 31, 2024

Equity [Abstract]

EQUITY TRANSACTIONS

NOTE E – EQUITY TRANSACTIONS

Preferred Stock

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $1.00 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value..

During the nine months ended January 31, 2024, the Company:

● Sold to eleven accredited investors 2,230,094 shares of common stock for cash of $381,929, actual shares were not issued yet and recorded as common stock to be issued.

● Issued 60,000 shares valued at $10,000 upon the conversion of preferred series C shares

● Issued 536,824 shares valued at $134,206 upon the conversion of preferred series D shares

Common Stock:

The Company is authorized to issue 750,000,000 shares of common stock, $0.001 par value. As of January 31, 2024 and April 30, 2023 the Company’s issued and outstanding shares are 26,141,023 and 23,045,205 respectively.

During the nine months ended January 31, 2024, the Company:

● Sold 2,976,906 shares valued at $243,875 issued for cash.

● Issued 346,995 shares to accredited investors for cash

● Issued 767,578 shares upon the conversion of shares of Series C and Series D Convertible Preferred Stock.

● Issued 1,861,000 shares valued at $156,975 to accredited investors upon conversion of promissory notes

● Issued 497,995 shares for consulting services valued at $48,491